Ekso Bionics Holdings, Inc.
EKSO
$0.4046
$0.02476.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.09M | 4.13M | 4.95M | 3.76M | 4.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.09M | 4.13M | 4.95M | 3.76M | 4.85M |
| Cost of Revenue | 2.38M | 1.92M | 2.31M | 1.81M | 2.48M |
| Gross Profit | 2.71M | 2.21M | 2.64M | 1.95M | 2.37M |
| SG&A Expenses | 4.69M | 4.07M | 3.86M | 4.07M | 5.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.32M | 6.77M | 7.29M | 7.01M | 8.30M |
| Operating Income | -2.23M | -2.64M | -2.34M | -3.26M | -3.45M |
| Income Before Tax | -3.41M | -2.07M | -2.42M | -3.43M | -3.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.41M | -2.07M | -2.42M | -3.43M | -3.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.41M | -2.07M | -2.42M | -3.43M | -3.21M |
| EBIT | -2.23M | -2.64M | -2.34M | -3.26M | -3.45M |
| EBITDA | -1.83M | -2.23M | -1.94M | -2.85M | -3.02M |
| EPS Basic | -0.14 | -0.10 | -0.13 | -0.20 | -0.22 |
| Normalized Basic EPS | -0.09 | -0.06 | -0.08 | -0.12 | -0.14 |
| EPS Diluted | -0.14 | -0.10 | -0.13 | -0.20 | -0.23 |
| Normalized Diluted EPS | -0.09 | -0.06 | -0.08 | -0.12 | -0.14 |
| Average Basic Shares Outstanding | 24.64M | 20.31M | 18.22M | 17.42M | 14.45M |
| Average Diluted Shares Outstanding | 24.64M | 20.31M | 18.22M | 17.42M | 14.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
